European network for fetal transplantation

Objective

In utero stem cell transplantation is a novel therapy targeted at the fetus, within the uterus early in a pregnancy. This therapy is intended to treat a genetic disorder, diagnosed within the first 12 weeks of gestation, before the pathological effects become manifested. Currently, there are some successful cases reported and European centres are in a leading position in the field. However, there is a pressing need for consensus in many aspects of this therapy and a consortium of European centres with expertise in many areas of stem cells and transplantation will be uniquely placed to ensure that the in utero procedure can be used to maximum benefit.

Programme(s)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Topic(s)

• 1.1.1.-7. - Chronic and degenerative diseases, cancer, diabetes, cardivascular diseases and rare diseases

Funding Scheme

CON - Coordination of research actions

Coordinator

UNIVERSITY OF NOTTINGHAM

Address

Queen's Medical Centre - University Hospital
NG7 2UH Nottingham
United Kingdom

Participants (8)

AZIENDA OSPEDALIERA "SPEDALI CIVILI" DI BRESCIA

Italy

Address

Piazzale Spedali Civili 1
25123 Brescia

HADASSAH UNIVERSITY HOSPITAL

Israel

Address

Ein Karem
91120 Jerusalem

HOSPICES CIVILS DE LYON

France

Address

Place D'arsonval
69437 Lyon

INTERNATIONAL BLOOD GROUP REFERENCE LABORATORY

United Kingdom

Address

Southmead Road
BS10 5ND Bristol

KAROLINSKA INSTITUTE

Sweden

Address

Karolinska Hospital
171 76 Stockholm

LEIDEN UNIVERSITY

Netherlands

Address

Albinusdreef 2
2300 RC Leiden

UNIVERSITY HOSPITAL

Switzerland

Address

Petersgraben 4
4031 Basel

WEIZMANN INSTITUTE OF SCIENCE

Israel

Address

Herzel Street 2
76100 Rehovot